Division V
1 – 10 of 8426
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
- The applicability of the translated Edmonton Symptom Assessment System : revised [ESAS-r] in Swedish palliative care
- The BRCA1 c. 5096G>A p.Arg1699Gln (R1699Q) intermediate risk variant : Breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium
- Building and validating a prediction model for paediatric type 1 diabetes risk using next generation targeted sequencing of class II HLA genes
- Prognostic and predictive importance of the estrogen receptor coactivator AIB1 in a randomized trial comparing adjuvant letrozole and tamoxifen therapy in postmenopausal breast cancer : the Danish cohort of BIG 1-98
- C1-inhibitor decreases the release of vasculitis-like chemotactic endothelial microvesicles
- Randomized, phase 3 trial of inotuzumab ozogamicin plus rituximab versus chemotherapy plus rituximab for relapsed/refractory aggressive B-cell non-Hodgkin lymphoma
- Mode of first delivery and severe maternal complications in the subsequent pregnancy
- In vivo retention of (18)F-AV-1451 in corticobasal syndrome
- Simulation of aortopulmonary collateral flow in Fontan patients for use in prediction of interventional outcomes
- Dynamic Susceptibility Contrast MRI at 7 T:Tail-Scaling Analysis and Inferences About Field Strength Dependence